Q1 Earnings Forecast for Sage Therapeutics Issued By Wedbush
Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Equities researchers at Wedbush upped their Q1 2025 EPS estimates for shares of Sage Therapeutics in a research note issued on Wednesday, April 16th. Wedbush analyst L. Chico now forecasts that the biopharmaceutical company will post earnings of ($1.17) per share for the quarter, up from their […]
Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Equities researchers at Wedbush upped their Q1 2025 EPS estimates for shares of Sage Therapeutics in a research note issued on Wednesday, April 16th. Wedbush analyst L. Chico now forecasts that the biopharmaceutical company will post earnings of ($1.17) per share for the quarter, up from their […]
